Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C6orf47 antisense RNA 1 (C6orf47-AS1) is a long non-coding RNA (lncRNA) gene transcribed antisense to the C6orf47 locus in humans. It belongs to the antisense RNA subclass of lncRNAs, which often modulate the expression, stability, or splicing of their sense counterparts (here, the C6orf47 gene) through base pairing and related mechanisms. No evidence currently designates C6orf47-AS1 as a therapeutic target, biomarker, or interacting partner for approved or experimental drugs. Functional details specific to C6orf47-AS1 remain largely undetermined, and it is mainly classified as an antisense lncRNA with presumed regulatory roles based on analogy with better-characterized antisense lncRNAs. No notable safety concerns or disease associations have been reported for C6orf47-AS1 as of the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C6orf47 antisense RNA 1 (C6orf47-AS1).